RFS Cancer Research Results

RFS, Relapse-Free Survival: Click to Expand ⟱
Source:
Type:

RFS - Relapse-Free Survival

Type: Clinical outcome / survival endpoint

Function: Measures the length of time following treatment during which a patient remains alive without recurrence or relapse of the original cancer. RFS is commonly used as an endpoint in oncology clinical trials and observational studies.

Direction: ↑ Longer RFS indicates a more favorable clinical outcome.
Scientific Papers found: Click to Expand⟱
7579- IMA,    One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
- Trial, GC, NA
RFS↑, OS↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

RFS↑, 1,  

Functional Outcomes(tgid=23) ⓘ

OS↑, 1,  
Total Targets: 2

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: RFS, Relapse-Free Survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1664  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page